Novartis AG Vs. Akero Therapeutics Industry Stock Comparison

Buy

60

NVS
Novartis AG

Last Price:

103.84

Seasonality Move:

1.51%

Buy

61

AKRO
Akero Therapeutics

Last Price:

31.22

Seasonality Move:

5.92%

Buy

60

Novartis AG (NVS) is a Buy

Is Novartis AG a Buy, Sell or Hold?

The current Novartis AG [NVS] share price is $103.09. The Score for NVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
NVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

61

Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

The current Akero Therapeutics [AKRO] share price is $30.64. The Score for AKRO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVS Stock Price Chart

What is Novartis AG's stock price today?

The Novartis AG share price today is $103.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

The Akero Therapeutics share price today is $30.64
The current trend is relatively stagnant and AKRO is experiencing slight selling pressure.

NVS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.93	Sell
Relative Strength Index (14 RSI):	24.7	Sell
Chaikin Money Flow:	761285	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(104.47 - 113.87)	Sell
Bollinger Bands (100):	(108.1 - 117)	Sell

AKRO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.2	Buy
Relative Strength Index (14 RSI):	49.43	Sell
Chaikin Money Flow:	-52673	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(29.33 - 33.05)	Sell
Bollinger Bands (100):	(24.84 - 30.44)	Buy

NVS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	103.79	Sell
20-day SMA:	107.56	Sell
50-day SMA:	112.31	Sell
200-day SMA:	106.39	Sell
8-day EMA:	104.12	Sell
20-day EMA:	106.99	Sell
50-day EMA:	110.35	Sell
200-day EMA:	107.81	Sell

AKRO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	30.68	Sell
20-day SMA:	31.41	Sell
50-day SMA:	29.63	Buy
200-day SMA:	25.21	Buy
8-day EMA:	30.77	Sell
20-day EMA:	30.97	Sell
50-day EMA:	29.78	Buy
200-day EMA:	27.2	Buy

Novartis AG Earnings Growth & NVS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

Novartis AG Technical Analysis

	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20
	Nov
	07	08	11	12	13	14	15	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20
	Nov
	07	08	11	12	13	14	15	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):